BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26259295)

  • 1. Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience.
    Dasanu CA; Bockorny B; Grabska J; Codreanu I
    Conn Med; 2015 Apr; 79(4):197-200. PubMed ID: 26259295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
    Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
    Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune phenomena in untreated and treated marginal zone lymphoma.
    Grabska J; Dasanu CA
    Expert Opin Pharmacother; 2011 Oct; 12(15):2369-79. PubMed ID: 21679092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.
    Olszewski AJ; Castillo JJ
    Cancer; 2013 Feb; 119(3):629-38. PubMed ID: 22893605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the marginal zone lymphomas.
    Vannata B; Stathis A; Zucca E
    Cancer Treat Res; 2015; 165():227-49. PubMed ID: 25655612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
    Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
    Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
    Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
    Michot JM; Canioni D; Driss H; Alric L; Cacoub P; Suarez F; Sibon D; Thieblemont C; Dupuis J; Terrier B; Feray C; Tilly H; Pol S; Leblond V; Settegrana C; Rabiega P; Barthe Y; Hendel-Chavez H; Nguyen-Khac F; Merle-Béral H; Berger F; Molina T; Charlotte F; Carrat F; Davi F; Hermine O; Besson C;
    Am J Hematol; 2015 Mar; 90(3):197-203. PubMed ID: 25417909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
    Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
    Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
    Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous involvement with marginal zone lymphoma.
    Gerami P; Wickless SC; Querfeld C; Rosen ST; Kuzel TM; Guitart J
    J Am Acad Dermatol; 2010 Jul; 63(1):142-5. PubMed ID: 20462658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marginal zone lymphoma in elderly and geriatric patients.
    Goede V
    Best Pract Res Clin Haematol; 2017; 30(1-2):158-165. PubMed ID: 28288711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
    Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
    Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Splenic marginal zone B-cell lymphoma with epidermotropic skin involvement].
    Gómez-de la Fuente E; Villalón LB; Calzado-Villarreal L; Pinedo-Moraleda F; López-Estebaranz JL
    Actas Dermosifiliogr; 2012 Jun; 103(5):427-31. PubMed ID: 21885023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Bracci PM; Benavente Y; Turner JJ; Paltiel O; Slager SL; Vajdic CM; Norman AD; Cerhan JR; Chiu BC; Becker N; Cocco P; Dogan A; Nieters A; Holly EA; Kane EV; Smedby KE; Maynadié M; Spinelli JJ; Roman E; Glimelius B; Wang SS; Sampson JN; Morton LM; de Sanjosé S
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):52-65. PubMed ID: 25174026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases.
    Trejo O; Ramos-Casals M; López-Guillermo A; García-Carrasco M; Yagüe J; Cervera R; Font J; Ingelmo M
    Semin Arthritis Rheum; 2003 Aug; 33(1):19-28. PubMed ID: 12920693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases.
    Oh SY; Kim WS; Kim SJ; Kim JS; Kim SH; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Kim JG; Yang DH; Kang HJ; Choi CW; Park J; Choi YJ; Kim HJ; Kwon JH; Suh C; Kim HJ
    Am J Hematol; 2009 Dec; 84(12):826-9. PubMed ID: 19890833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
    Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
    Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.